Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02200380
Title A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Celldex Therapeutics
Indications

non-Hodgkin lymphoma

chronic myeloid leukemia

Hodgkin's lymphoma

chronic lymphocytic leukemia

bone marrow cancer

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

Plerixafor

CDX-301

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Medical Center Los Angeles California 90095 United States Details
Emory University-Winship Cancer Institute Atlanta Georgia 30322 United States Details
Indiana Blood and Marrow Transplant Indianapolis Indiana 46237 United States Details
University of Iowa Iowa City Iowa 52242 United States Details
Wake Forest Baptist Health Winston-Salem North Carolina 27157 United States Details
Ohio State University Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Columbus Ohio 43210 United States Details
University of Virginia Medical Center Charlottesville Virginia 22908 United States Details
Virginia Commonwealth University Medical Center Richmond Virginia 23298 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field